Showing posts with label pharmacological industry. Show all posts
Showing posts with label pharmacological industry. Show all posts
Thursday, 12 November 2020

Take sustainability serious in healthcare to avoid harming future patients!

›
  In a brand new blog post at the BMJ Journal of Medical Ethics blog , me, Davide Fumagalli and Erik Malmqvist write about a severe ethical...
Sunday, 6 March 2016

Personalised, Individualised or Precision Medicine: Three Unaddressed Socio-economic Hurdles

›
After the BRAIN initiative of 2013, in 2015 US president Obama announced another large scale government funding scheme for biomedical sc...
Monday, 6 July 2015

The Ethics of Pharmaceutical Pricing

›
I don't think I'm alone in having noticed in my own country – as well as throughout that part of the developed world where states...
Friday, 10 April 2015

This is Huge: Serious Research Misconduct in Almost 3/4 of FDA Inspected Clinical Trials – Hidden by Both Inspecting Agency and Researchers

›
First I had problems taking it in: Almost 75% of US clinical trials inspected over a period of 15 years by the Food and Drug Agency, respon...
1 comment:
Wednesday, 19 February 2014

UK Medical Records Sellout Delayed: NHS Realises It Needs to Inform People of their Rights

›
So, some of you may recall my rather negative comments on a UK national plan to make NHS medical records which are not even fully anonymised...
Sunday, 19 January 2014

UK Set to Sell Out it's Population's Medical Data and Records to Private Industry and Health Insurers

›
I posted almost a year back about a then apparently more restrictive, but to my eyes still outrageous, move of the UK government to frivolo...
Saturday, 12 May 2012

Senate Probe into Pharma Sponsoring of US Bioethics Center

›
The last few days, a buzz in the world of bioethics has been about the inclusion into a US Senate probe into the ties between the pain-kille...
Thursday, 22 September 2011

Pharma Corps put Money Before Swedish Women's Health, But Why Be Surprised?

›
Today, the Swedish branch of the international pharma corporation GlaxoSmithKlein (GSK) announced that it will appeal the decision of the u...
7 comments: